>
Switch to:

Sorrento Therapeutics EV-to-EBITDA

: -7.70 (As of Today)
View and export this data going back to 2007. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sorrento Therapeutics's enterprise value is $2,152.39 Mil. Sorrento Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was $-279.39 Mil. Therefore, Sorrento Therapeutics's EV-to-EBITDA for today is -7.70.

NAS:SRNE' s EV-to-EBITDA Range Over the Past 10 Years
Min: -182.5   Med: -7.54   Max: 205.52
Current: -7.7

-182.5
205.52

During the past 13 years, the highest EV-to-EBITDA of Sorrento Therapeutics was 205.52. The lowest was -182.50. And the median was -7.54.

NAS:SRNE's EV-to-EBITDA is ranked lower than
99.99% of the 296 Companies
in the Biotechnology industry.

( Industry Median: 27.62 vs. NAS:SRNE: -7.70 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-05-08), Sorrento Therapeutics's stock price is $7.20. Sorrento Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-1.30. Therefore, Sorrento Therapeutics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Sorrento Therapeutics EV-to-EBITDA Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sorrento Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.62 11.06 -2.50 -2.53 -7.04

Sorrento Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.53 -2.35 -6.36 -11.16 -7.04

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Sorrento Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where Sorrento Therapeutics's EV-to-EBITDA falls into.



Sorrento Therapeutics EV-to-EBITDA Calculation

Sorrento Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2152.394/-279.392
=-7.70

Sorrento Therapeutics's current Enterprise Value is $2,152.39 Mil.
Sorrento Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was -59.017 (Mar. 2020 ) + -71.321 (Jun. 2020 ) + -80.698 (Sep. 2020 ) + -68.356 (Dec. 2020 ) = $-279.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sorrento Therapeutics  (NAS:SRNE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sorrento Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.20/-1.3
=

Sorrento Therapeutics's share price for today is $7.20.
Sorrento Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was -0.36 (Mar. 2020 ) + -0.36 (Jun. 2020 ) + -0.33 (Sep. 2020 ) + -0.25 (Dec. 2020 ) = $-1.30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Sorrento Therapeutics EV-to-EBITDA Related Terms


Sorrento Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)